Two-Year Results of the Phase 3 Randomized Controlled Study of Abicipar in Neovascular Age-Related Macular Degeneration
| Overview / Abstract: |
September 2021: VBS Literature Update Khurana RN, Kunimoto D, Yoon YH, et al. Two-year results of the phase 3 randomized controlled study of abicipar in neovascular age-related macular degeneration. Ophthalmology. 2021;128(7):1027-1038. |
|
Expiration |
Sep 03, 2022 |
|
Discipline(s) |
Optometry / Ophthalmology CE |
|
Format |
Journal |
|
Credits / Hours |
0.5 |
|
Accreditation |
ACCME |
|
Keywords / Search Terms |
Evolve Medical Education LLC Free CE CME |
|